DHA and Alzheimer’s Disease: A Possible Protective Mechanism
Research published in the Journal of Neuroscience (December 26, 2007) explored a possible mechanism by which docosahexaenoic acid (DHA)—an omega-3 fatty acid commonly found in fish oil—may help protect brain tissue.
In this laboratory study, researchers examined rat neurons and found that DHA increased the production of a protein known as LR11. LR11 plays a regulatory role in the processing of amyloid precursor protein (APP). APP is involved in the formation of beta-amyloid plaques, which are a hallmark of Alzheimer’s disease. By increasing LR11 levels, DHA appeared to reduce the activity of enzymes involved in plaque formation.
This study did not examine humans and does not prove that DHA prevents or treats Alzheimer’s disease. However, it provides insight into a biological pathway through which omega-3 fatty acids may influence processes linked to neurodegeneration.
Earlier observational and clinical studies have suggested that higher intake of omega-3 fatty acids is associated with slower cognitive decline in aging populations. While human studies are still needed to clarify the extent of DHA’s protective effects, this research helps explain how omega-3 fatty acids might support brain health at the cellular level.
This article is for educational purposes only and is not intended as medical advice.
